Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2010, Article ID 783273, 10 pages
http://dx.doi.org/10.1155/2010/783273
Review Article

PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways

1Service de Physiologie, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, 94275 Le Kremlin-Bicêtre, France
2Département de Physiologie Humaine, Université Paris 11 Sud, 94275, Le Kremlin-Bicêtre, France
3Centre de Recherche Clinique, Centre Hospitalier Régional de Meaux, 77100, Meaux, France
4Department of Pharmaceutical Sciences, University of Antwerpen, 2670, Wilrijk, Belgium

Received 19 April 2010; Accepted 16 June 2010

Academic Editor: Brian Finck

Copyright © 2010 Yves Lecarpentier et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Desvergne and W. Wahli, “Peroxisome proliferator-activated receptors: nuclear control of metabolism,” Endocrine Reviews, vol. 20, no. 5, pp. 649–688, 1999. View at Google Scholar · View at Scopus
  2. F. Djouadi, C. J. Weinheimer, J. E. Saffitz et al., “A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice,” Journal of Clinical Investigation, vol. 102, no. 6, pp. 1083–1091, 1998. View at Google Scholar · View at Scopus
  3. S. Kersten, B. Desvergne, and W. Wahli, “Roles of PPARS in health and disease,” Nature, vol. 405, no. 6785, pp. 421–424, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Watanabe, H. Fujii, T. Takahashi et al., “Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α associated with age-dependent cardiac toxicity,” Journal of Biological Chemistry, vol. 275, no. 29, pp. 22293–22299, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. B. N. Finck, G. Chinetti, and B. Staels, “PPARs/RXRs in cardiovascular physiology and disease,” PPAR Research, vol. 2008, Article ID 173780, 1 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. B. N. Finck and D. P. Kelly, “Peroxisome proliferator-activated receptor γ coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease,” Circulation, vol. 115, no. 19, pp. 2540–2548, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Huss and D. P. Kelly, “Nuclear receptor signaling and cardiac energetics,” Circulation Research, vol. 95, no. 6, pp. 568–578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Huss and D. P. Kelly, “Mitochondrial energy metabolism in heart failure: a question of balance,” Journal of Clinical Investigation, vol. 115, no. 3, pp. 547–555, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. Q. Yang and Y. Li, “Roles of PPARs on regulating myocardial energy and lipid homeostasis,” Journal of Molecular Medicine, vol. 85, no. 7, pp. 697–706, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Lockyer, J. C. Schisler, C. Patterson, and M. S. Willis, “Minireview: Won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart,” Molecular Endocrinology, vol. 24, no. 6, pp. 1111–1119, 2009. View at Google Scholar
  11. F. Djouadi, Y. Lecarpentier, J. L. Hébert, P. Charron, J. Bastin, and C. Coirault, “A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy,” Cardiovascular Research, vol. 84, no. 1, pp. 83–90, 2009. View at Google Scholar · View at Scopus
  12. A. Goldbeter and R. Lefever, “Dissipative structures for an allosteric model. Application to glycolytic oscillations,” Biophysical Journal, vol. 12, no. 10, pp. 1302–1315, 1972. View at Google Scholar · View at Scopus
  13. G. Nicolis, “Nonlinear kinetics: at the crossroads of chemistry, physics and life sciences,” Faraday Discussions, vol. 120, pp. 1–10, 2001. View at Google Scholar · View at Scopus
  14. D. Kondepudi and I. Prigogine, Modern Thermodynamics from Heat Engines to Dissipative Structures, John Wiley & Sons, New York, NY, USA, 1999.
  15. I. Prigogine, G. Nicolis, and A. Babloyantz, “Nonequilibrium problems in biological phenomena,” Annals of the New York Academy of Sciences, vol. 231, pp. 99–105, 1974. View at Google Scholar · View at Scopus
  16. A. Guellich, T. Damy, Y. Lecarpentier et al., “Role of oxidative stress in cardiac dysfunction of PPARα -/- mice,” American Journal of Physiology, vol. 293, no. 1, pp. H93–H102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. L. F. Olsen and H. Degn, “Oscillatory kinetics of the peroxidase-oxidase reaction in an open system. Experimental and theoretical studies,” Biochimica et Biophysica Acta, vol. 523, no. 2, pp. 321–334, 1978. View at Google Scholar · View at Scopus
  18. P. Glansdorff, G. Nicolis, and I. Prigogine, “The thermodynamic stability theory of non-equilibrium states,” Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 1, pp. 197–199, 1974. View at Google Scholar
  19. Y. Lecarpentier, X. Krokidis, P. Martin et al., “Increased entropy production in diaphragm muscle of PPARα knockout mice,” Journal of Theoretical Biology, vol. 250, no. 1, pp. 92–102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Prigogine and G. Nicolis, “Biological order, structure and instabilities,” Quarterly Reviews of Biophysics, vol. 4, no. 2, pp. 107–148, 1971. View at Google Scholar · View at Scopus
  21. R. Lefever, N. Barbier, P. Couteron, and O. Lejeune, “Deeply gapped vegetation patterns: on crown/root allometry, criticality and desertification,” Journal of Theoretical Biology, vol. 261, no. 2, pp. 194–209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Goldbeter, “Computational approaches to cellular rhythms,” Nature, vol. 420, no. 6912, pp. 238–245, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. F. I. Marcus, G. H. Fontaine, and G. Guiraudon, “Right ventricular dysplasia: a report of 24 adult cases,” Circulation, vol. 65, no. 2, pp. 384–398, 1982. View at Google Scholar · View at Scopus
  24. G. Fontaine, F. Fontaliran, J. L. Hébert et al., “Arrhythmogenic right ventricular dysplasia,” Annual Review of Medicine, vol. 50, pp. 17–35, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Corrado, C. Basso, G. Thiene et al., “Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study,” Journal of the American College of Cardiology, vol. 30, no. 6, pp. 1512–1520, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Richardson, R. W. McKenna, M. Bristow et al., “Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies,” Circulation, vol. 93, no. 5, pp. 841–842, 1996. View at Google Scholar · View at Scopus
  27. J.-L. Hébert, D. Chemla, O. Gérard et al., “Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia,” American Journal of Cardiology, vol. 93, no. 6, pp. 728–733, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Basso, D. Corrado, F. I. Marcus, A. Nava, and G. Thiene, “Arrhythmogenic right ventricular cardiomyopathy,” The Lancet, vol. 373, no. 9671, pp. 1289–1300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Fressart, G. Duthoit, E. Donal et al., “Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice,” Europace, vol. 12, no. 6, pp. 861–868, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Heuberger and W. Birchmeier, “Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling,” Cold Spring Harbor Perspectives in Biology, vol. 2, no. 2, Article ID a002915, 2010. View at Google Scholar
  31. I. Takada, A. P. Kouzmenko, and S. Kato, “Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis,” Nature Reviews Rheumatology, vol. 5, no. 8, pp. 442–447, 2009. View at Google Scholar · View at Scopus
  32. E. Garcia-Gras, R. Lombardi, M. J. Giocondo et al., “Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 2012–2021, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. S. E. Ross, N. Hemati, K. A. Longo et al., “Inhibition of adipogenesis by Wnt signaling,” Science, vol. 289, no. 5481, pp. 950–953, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Lombardi, J. Dong, G. Rodriguez et al., “Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy,” Circulation Research, vol. 104, no. 9, pp. 1076–1084, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Tandri, A. Asimaki, D. Dalal, J. E. Saffitz, M. K. Halushka, and H. Calkins, “Gap junction remodeling in a case of arrhythmogenic right ventricular dysplasia due to plakophilin-2 mutation,” Journal of Cardiovascular Electrophysiology, vol. 19, no. 11, pp. 1212–1214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. G. d'Amati, C. R. T. di Gioia, C. Giordano, and P. Gallo, “Myocyte transdifferentiation: a possible pathogenetic mechanism for arrhythmogenic right ventricular cardiomyopathy,” Archives of Pathology and Laboratory Medicine, vol. 124, no. 2, pp. 287–290, 2000. View at Google Scholar · View at Scopus
  37. A. Goldbeter and O. Pourquié, “Modeling the segmentation clock as a network of coupled oscillations in the Notch, Wnt and FGF signaling pathways,” Journal of Theoretical Biology, vol. 252, no. 3, pp. 574–585, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Prigogine, R. Lefever, A. Goldbeter, and M. Herschkowitz-Kaufman, “Symmetry breaking instabilities in biological systems,” Nature, vol. 223, no. 5209, pp. 913–916, 1969. View at Publisher · View at Google Scholar · View at Scopus
  39. M. S. Bray and M. E. Young, “Diurnal variations in myocardial metabolism,” Cardiovascular Research, vol. 79, no. 2, pp. 228–237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Edery, “Circadian rhythms in a nutshell,” Physiol Genomics, vol. 3, no. 2, pp. 59–74, 2000. View at Google Scholar · View at Scopus
  41. D. Stoleru, P. Nawathean, M. D. L. P. Fernández, J. S. Menet, M. F. Ceriani, and M. Rosbash, “The Drosophila circadian network is a seasonal timer,” Cell, vol. 129, no. 1, pp. 207–219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. J. C. Dunlap, “Molecular bases for circadian clocks,” Cell, vol. 96, no. 2, pp. 271–290, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. P. E. Hardin, “Transcription regulation within the circadian clock: the E-box and beyond,” Journal of Biological Rhythms, vol. 19, no. 5, pp. 348–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Gekakis, D. Staknis, H. B. Nguyen et al., “Role of the CLOCK protein in the mammalian circadian mechanism,” Science, vol. 280, no. 5369, pp. 1564–1569, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. J. B. Hogenesch, Y.-Z. Gu, S. Jain, and C. A. Bradfield, “The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 10, pp. 5474–5479, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Duez and B. Staels, “Rev-erb-α: an integrator of circadian rhythms and metabolism,” Journal of Applied Physiology, vol. 107, no. 6, pp. 1972–1980, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. D. J. Durgan, M. A. Hotze, T. M. Tomlin et al., “The intrinsic circadian clock within the cardiomyocyte,” American Journal of Physiology, vol. 289, no. 4, pp. H1530–H1541, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. H. R. Ueda, W. Chen, A. Adachi et al., “A transcription factor response element for gene expression during circadian night,” Nature, vol. 418, no. 6897, pp. 534–539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. S. R. Bergmann, P. Herrero, R. Sciacca et al., “Characterization of altered myocardial fatty acid metabolism in patients with inherited cardiomyopathy,” Journal of Inherited Metabolic Disease, vol. 24, no. 6, pp. 657–674, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Taha and G. D. Lopaschuk, “Alterations in energy metabolism in cardiomyopathies,” Annals of Medicine, vol. 39, no. 8, pp. 594–607, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. J. J. Lehman and D. P. Kelly, “Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart,” Clinical and Experimental Pharmacology and Physiology, vol. 29, no. 4, pp. 339–345, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. W. C. Stanley and M. P. Chandler, “Energy metabolism in the normal and failing heart: potential for therapeutic interventions,” Heart Failure Reviews, vol. 7, no. 2, pp. 115–130, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Neubauer, “The failing heart—an engine out of fuel,” The New England Journal of Medicine, vol. 356, no. 11, pp. 1140–1151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. M. van den Buuse, “Circadian rhythms of blood pressure and heart rate in conscious rats: effects of light cycle shift and timed feeding,” Physiology and Behavior, vol. 68, no. 1-2, pp. 9–15, 1999. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Oosting, H. A. J. Struijker-Boudier, and B. J. A. Janssen, “Circadian and ultradian control of cardiac output in spontaneous hypertension in rats,” American Journal of Physiology, vol. 273, no. 1, pp. H66–H75, 1997. View at Google Scholar · View at Scopus
  56. M. S. Bray, C. A. Shaw, M. W. S. Moore et al., “Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression,” American Journal of Physiology, vol. 294, no. 2, pp. H1036–H1047, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. M. A. Stavinoha, J. W. RaySpellicy, M. L. Hart-Sailors, H. J. Mersmann, M. S. Bray, and M. E. Young, “Diurnal variations in the responsiveness of cardiac and skeletal muscle to fatty acids,” American Journal of Physiology, vol. 287, no. 5, pp. E878–E887, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. D. J. Durgan, N. A. Trexler, O. Egbejimi et al., “The circadian clock within the cardiomyocyte is essential for responsiveness of the heart to fatty acids,” Journal of Biological Chemistry, vol. 281, no. 34, pp. 24254–24269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. P. M. Barger and D. P. Kelly, “PPAR signaling in the control of cardiac energy metabolism,” Trends in Cardiovascular Medicine, vol. 10, no. 6, pp. 238–245, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Oishi, H. Shirai, and N. Ishida, “CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor α (PPARα) in mice,” Biochemical Journal, vol. 386, no. 3, pp. 575–581, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. N. Wang, G. Yang, Z. Jia et al., “Vascular PPARγ controls circadian variation in blood pressure and heart rate through Bmal1,” Cell Metabolism, vol. 8, no. 6, pp. 482–491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. F. Anan, T. Masaki, N. Fukunaga et al., “Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus,” European Journal of Clinical Investigation, vol. 37, no. 9, pp. 709–714, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. A. M. Curtis, Y. Cheng, S. Kapoor, D. Reilly, T. S. Price, and G. A. FitzGerald, “Circadian variation of blood pressure and the vascular response to asynchronous stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 9, pp. 3450–3455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Masuki, T. Todo, Y. Nakano, H. Okamura, and H. Nose, “Reduced α-adrenoceptor responsiveness and enhanced baroreflex sensitivity in Cry-deficient mice lacking a biological clock,” Journal of Physiology, vol. 566, no. 1, pp. 213–224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. J. P. Berger, T. E. Akiyama, and P. T. Meinke, “PPARs: therapeutic targets for metabolic disease,” Trends in Pharmacological Sciences, vol. 26, no. 5, pp. 244–251, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. R. M. Evans, G. D. Barish, and Y.-X. Wang, “PPARs and the complex journey to obesity,” Nature Medicine, vol. 10, no. 4, pp. 355–361, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Canaple, J. Rambaud, O. Dkhissi-Benyahya et al., “Reciprocal regulation of brain and muscle Arnt-like protein 1 and peroxisome proliferator-activated receptor α defines a novel positive feedback loop in the rodent liver circadian clock,” Molecular Endocrinology, vol. 20, no. 8, pp. 1715–1727, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. J. E. Muller, “Circadian variation and triggering of acute coronary events,” American Heart Journal, vol. 137, no. 4, part 2, pp. S1–S8, 1999. View at Google Scholar · View at Scopus
  69. J. E. Muller, “Circadian variation in cardiovascular events,” American Journal of Hypertension, vol. 12, no. 2, pp. 35S–42S, 1999. View at Google Scholar · View at Scopus
  70. R. D. Rudic, P. McNamara, A.-M. Curtis et al., “BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis,” PLoS Biology, vol. 2, no. 11, article e377, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Kohsaka, A. D. Laposky, K. M. Ramsey et al., “High-fat diet disrupts behavioral and molecular circadian rhythms in mice,” Cell Metabolism, vol. 6, no. 5, pp. 414–421, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. F. W. Turek, C. Joshu, A. Kohsaka et al., “Obesity and metabolic syndrome in circadian Clock mutant nice,” Science, vol. 308, no. 5724, pp. 1043–1045, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. B. C. Goodwin, “Oscillatory behavior in enzymatic control processes,” Advances in Enzyme Regulation, vol. 3, no. C, pp. 425–438, 1965. View at Google Scholar · View at Scopus
  74. A. Goldbeter, “A model for circadian oscillations in the Drosophila period protein (PER),” Proceedings of the Royal Society B, vol. 261, no. 1362, pp. 319–324, 1995. View at Publisher · View at Google Scholar · View at Scopus
  75. O. Pourquié and A. Goldbeter, “Segmentation clock: insights from computational models,” Current Biology, vol. 13, no. 16, pp. R632–R634, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Aulehla, C. Wehrle, B. Brand-Saberi et al., “Wnt3a plays a major role in the segmentation clock controlling somitogenesis,” Developmental Cell, vol. 4, no. 3, pp. 395–406, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. B. N. Finck, “Effects of PPARα on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle?” Expert Review of Cardiovascular Therapy, vol. 4, no. 2, pp. 161–171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. B. N. Finck, J. J. Lehman, T. C. Leone et al., “The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus,” Journal of Clinical Investigation, vol. 109, no. 1, pp. 121–130, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. M. C. Sugden, M. G. Zariwala, and M. J. Holness, “PPARs and the orchestration of metabolic fuel selection,” Pharmacological Research, vol. 60, no. 3, pp. 141–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. P. J. Randle, P. B. Garland, C. N. Hales, and E. A. Newsholme, “The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus,” The Lancet, vol. 281, no. 7285, pp. 785–789, 1963. View at Google Scholar · View at Scopus
  81. M. Jové, J. Salla, A. Planavila et al., “Impaired expression of NADH dehydrogenase subunit 1 and PPARγ coactivator-1 in skeletal muscle of ZDF rats: restoration by troglitazone,” Journal of Lipid Research, vol. 45, no. 1, pp. 113–123, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Goldbeter, “Patterns of spatiotemporal organization in an allosteric enzyme model,” Proceedings of the National Academy of Sciences of the United States of America, vol. 70, no. 11, pp. 3255–3259, 1973. View at Google Scholar · View at Scopus
  83. A. Goldbeter and D. Venieratos, “Analysis of the role of enzyme co-operativity in metabolic oscillations,” Journal of Molecular Biology, vol. 138, no. 1, pp. 137–144, 1980. View at Google Scholar · View at Scopus
  84. A. Goldbeter and G. Dupont, “Allosteric regulation, cooperativity, and biochemical oscillations,” Biophysical Chemistry, vol. 37, no. 1-3, pp. 341–353, 1990. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Boiteux, A. Goldbeter, and B. Hess, “Control of oscillating glycolysis of yeast by stochastic, periodic, and steady source of substrate: a model and experimental study,” Proceedings of the National Academy of Sciences of the United States of America, vol. 72, no. 10, pp. 3829–3833, 1975. View at Google Scholar · View at Scopus
  86. F. M. Campbell, R. Kozak, A. Wagner et al., “A role for peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARα are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase,” Journal of Biological Chemistry, vol. 277, no. 6, pp. 4098–4103, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Loichot, L. Jesel, A. Tesse et al., “Deletion of peroxisome proliferator-activated receptor-α induces an alteration of cardiac functions,” American Journal of Physiology, vol. 291, no. 1, pp. H161–H166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. I. Luptak, J. A. Balschi, Y. Xing, T. C. Leone, D. P. Kelly, and R. Tian, “Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-α-null hearts can be rescued by increasing glucose transport and utilization,” Circulation, vol. 112, no. 15, pp. 2339–2346, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Coirault, F. Lambert, J.-C. Pourny, and Y. Lecarpentier, “Velocity of actomyosin sliding in vitro is reduced in dystrophic mouse diaphragm,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 2, pp. 250–253, 2002. View at Google Scholar · View at Scopus
  90. D. E. Harris, S. S. Work, R. K. Wright, N. R. Alpert, and D. M. Warshaw, “Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro,” Journal of Muscle Research and Cell Motility, vol. 15, no. 1, pp. 11–19, 1994. View at Google Scholar · View at Scopus
  91. D. I. Keller, C. Coirault, T. Rau et al., “Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties,” Journal of Molecular and Cellular Cardiology, vol. 36, no. 3, pp. 355–362, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Lecarpentier, N. Vignier, P. Oliviero, A. Guellich, L. Carrier, and C. Coiraulty, “Cardiac myosin-binding protein C modulates the tuning of the molecular motor in the heart,” Biophysical Journal, vol. 95, no. 2, pp. 720–728, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Borbély, A. Tóth, I. Édes et al., “Peroxynitrite-induced α-actinin nitration and contractile alterations in isolated human myocardial cells,” Cardiovascular Research, vol. 67, no. 2, pp. 225–233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. P. Ferdinandy, “Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia,” British Journal of Pharmacology, vol. 138, no. 2, pp. 283–285, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. P. Ferdinandy, “Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well?” British Journal of Pharmacology, vol. 148, no. 1, pp. 1–3, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. M. J. Mihm, C. M. Coyle, B. L. Schanbacher, D. M. Weinstein, and J. A. Bauer, “Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure,” Cardiovascular Research, vol. 49, no. 4, pp. 798–807, 2001. View at Publisher · View at Google Scholar · View at Scopus
  97. R. Radi, “Nitric oxide, oxidants, and protein tyrosine nitration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 12, pp. 4003–4008, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. M. B. Reid, “Invited review: redox modulation of skeletal muscle contraction: what we know and what we don't,” Journal of Applied Physiology, vol. 90, no. 2, pp. 724–731, 2001. View at Google Scholar · View at Scopus
  99. Y. Lecarpentier, “Physiological role of free radicals in skeletal muscles,” Journal of Applied Physiology, vol. 103, no. 6, pp. 1917–1918, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. W. Dröge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002. View at Google Scholar · View at Scopus
  101. P. Ferdinandy, H. Danial, I. Ambrus, R. A. Rothery, and R. Schulz, “Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure,” Circulation Research, vol. 87, no. 3, pp. 241–247, 2000. View at Google Scholar · View at Scopus
  102. M. E. Poynter and R. A. Daynes, “Peroxisome proliferator-activated receptor α activation modulates cellular redox status, represses nuclear factor-κB signaling, and reduces inflammatory cytokine production in aging,” Journal of Biological Chemistry, vol. 273, no. 49, pp. 32833–32841, 1998. View at Publisher · View at Google Scholar · View at Scopus
  103. H. Takano, H. Hasegawa, T. Nagai, and I. Komuro, “The role of PPARgamma-dependent pathway in the development of cardiac hypertrophy,” Timely Topics In Medicine. Cardiovascular Diseases, vol. 9, p. E10, 2005. View at Google Scholar
  104. T. Toyama, H. Nakamura, Y. Harano et al., “PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats,” Biochemical and Biophysical Research Communications, vol. 324, no. 2, pp. 697–704, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. A. Fukuda, T. Osawa, K. Hitomi, and K. Uchida, “4-hydroxy-2-nonenal cytotoxicity in renal proximal tubular cells: protein modification and redox alteration,” Archives of Biochemistry and Biophysics, vol. 333, no. 2, pp. 419–426, 1996. View at Publisher · View at Google Scholar · View at Scopus
  106. Y. Li, T.-T. Huang, E. J. Carlson et al., “Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase,” Nature Genetics, vol. 11, no. 4, pp. 376–381, 1995. View at Google Scholar · View at Scopus
  107. H. Van Remmen, M. D. Williams, Z. Guo et al., “Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis,” American Journal of Physiology, vol. 281, no. 3, pp. H1422–H1432, 2001. View at Google Scholar · View at Scopus
  108. M. Canton, I. Neverova, R. Menabò, J. Van Eyk, and F. Di Lisa, “Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts,” American Journal of Physiology, vol. 286, no. 3, pp. H870–H877, 2004. View at Google Scholar · View at Scopus
  109. J. Murray, S. W. Taylor, B. Zhang, S. S. Ghosh, and R. A. Capaldi, “Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry,” Journal of Biological Chemistry, vol. 278, no. 39, pp. 37223–37230, 2003. View at Publisher · View at Google Scholar · View at Scopus
  110. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. P. M. Barger, J. M. Brandt, T. C. Leone, C. J. Weinheimer, and D. P. Kelly, “Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth,” Journal of Clinical Investigation, vol. 105, no. 12, pp. 1723–1730, 2000. View at Google Scholar · View at Scopus
  112. P. Razeghi, M. E. Young, S. Abbasi, and H. Taegtmeyer, “Hypoxia in vivo decreases peroxisome proliferator-activated receptor α-regulated gene expression in rat heart,” Biochemical and Biophysical Research Communications, vol. 287, no. 1, pp. 5–10, 2001. View at Publisher · View at Google Scholar · View at Scopus
  113. P. Razeghi, M. E. Young, J. L. Alcorn, C. S. Moravec, O. H. Frazier, and H. Taegtmeyer, “Metabolic gene expression in fetal and failing human heart,” Circulation, vol. 104, no. 24, pp. 2923–2931, 2001. View at Google Scholar · View at Scopus
  114. M. N. Sack, T. A. Rader, S. Park, J. Bastin, S. A. McCune, and D. P. Kelly, “Fatty acid oxidation enzyme gene expression is downregulated in the failing heart,” Circulation, vol. 94, no. 11, pp. 2837–2842, 1996. View at Google Scholar · View at Scopus
  115. J. C. Osorio, W. C. Stanley, A. Linke et al., “Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-α in pacing-induced heart failure,” Circulation, vol. 106, no. 5, pp. 606–612, 2002. View at Publisher · View at Google Scholar · View at Scopus
  116. I. Prigogine, Introduction to Thermodynamics of Irreversible Processes, John Wiley & Sons, New York, NY, USA, 1967.
  117. P. Glansdorff and I. Prigogine, Thermodynamics of Structure Stability and Fluctuations, John Wiley & Sons, New York, NY, USA, 1971.
  118. B. C. Goodwin and M. H. Cohen, “A phase-shift model for the spatial and temporal organization of developing systems,” Journal of Theoretical Biology, vol. 25, no. 1, pp. 49–107, 1969. View at Google Scholar · View at Scopus
  119. C. H. Waddington and R. J. Cowe, “Computer simulation of a Mulluscan pigmentation pattern,” Journal of Theoretical Biology, vol. 25, no. 2, pp. 219–225, 1969. View at Google Scholar · View at Scopus
  120. A. M. Turing, “The chemical basis of morphogenesis,” Bulletin of Mathematical Biology, vol. 52, no. 1-2, pp. 153–197, 1990. View at Publisher · View at Google Scholar · View at Scopus